SCHEMBL174238

SCHEMBL174238

Cc1ccccc1NC(=O)Nc1cccc2c1CCN2

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DDX3X O00571 2/20 0.52
MAPT P10636 5/20 0.50
TP53 P04637 2/20 0.50
RAB9A P51151 5/20 0.49
NPC1 O15118 4/20 0.49
KDR P35968 1/20 0.48
POLB P06746 1/20 0.47
L3MBTL1 Q9Y468 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
ALDH1A1 P00352 2/20 0.46
GAA P10253 1/20 0.46
ALOX15 P16050 1/20 0.46
HSD17B10 Q99714 1/20 0.46
HPGD P15428 1/20 0.45
ITGB3 P05106 1/20 0.44
ITGB1 P05556 1/20 0.44
ITGAV P06756 1/20 0.44
ITGA5 P08648 1/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4569778 0.84 MEN1 (0.53) DDX3XMAPTTP53RAB9ANPC1
SCHEMBL174930 0.84 RAB9A (0.52) MAPTTP53RAB9ANPC1KDR
SCHEMBL175199 0.83 HTT (0.51) MAPTRAB9ANPC1ALDH1A1GAA
SCHEMBL173758 0.83 SMN1; SMN2 (0.53) MAPTRAB9ANPC1POLBALDH1A1
SCHEMBL174986 0.82 KMT2A (0.52) DDX3XMAPTRAB9ANPC1KDR
SCHEMBL175017 0.81 GAA (0.56) L3MBTL1ALDH1A1GAAALOX15HSD17B10
SCHEMBL257377 0.81 GAA (0.45) MAPTRAB9ANPC1POLBL3MBTL1
Hydrochloric Acid SCHEMBL174066 0.81 KMT2A (0.51) DDX3XMAPTRAB9ANPC1KDR
SCHEMBL173797 0.80 MEN1 (0.54) RAB9ANPC1POLBALDH1A1MEN1
SCHEMBL174936 0.78 MEN1 (0.51) MAPTTP53RAB9ANPC1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611806-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS Ascepion Pharmaceuticals, Inc. (CN) 2013-07-10 EP claimed
WO-2012028106-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS ASCEPION PHARMACEUTICALS, INC. (CN) 2012-03-08 WO claimed
EP-2611806-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS Ascepion Pharmaceuticals, Inc. (CN) 2013-07-10 EP disclosed
WO-2012028106-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS ASCEPION PHARMACEUTICALS, INC. (CN) 2012-03-08 WO disclosed